Deals
The ASX is getting its first real taste of the UK retail billionaire’s infamously aggressive drive for corporate power.
Shareholders are resisting the low-ball bid from the toll road group’s most powerful investor. But there may be another path forward.
Plus: Meta shares fall as FT flags mega share sale ahead; SpaceX USD75b IPO already oversubscribed; Blowout jobs number cements Fed hike bets before year end.
SpaceX’s Australian IPO prospectus reveals early local winners.
The $2 billion medical imaging company and ASX market darling transformed itself in the space of 48 hours this week, with a geography expanding acquisition and a major product release.
One of the year’s biggest M&A battles descends into a war of words.
The board of the toll road group has the backing of at least one major shareholder. But a hostile takeover from its largest investor may be inevitable.
Anthropic files for IPO as biggest listing race ever takes shape.
